EB612 (EBP05) ( DrugBank: - )

1 disease

ID	Disease name (Link within this page)	Number of trials
235	Hypoparathyroidism	1

235. Hypoparathyroidism

Clinical trials : 88 / Drugs : 107 - (DrugBank : 24) / Drug target genes : 5 - Drug target pathways : 7

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03516773 (ClinicalTrials.gov)	June 17, 2018	23/4/2018	Oral PTH(1-34) PK and PD Study in Patients With Hypoparathyroidism	An Evaluation of the Pharmacokinetics and Pharmacodynamics of Oral Parathyroid Hormone [PTH (1-34)] ...	Hypoparathyroidism	Drug: EB612 (EBP05);Drug: NATPARA/NATPAR	Entera Bio Ltd.	NULL	Completed	18 Years	80 Years	All	20	Phase 2	Israel

First Previous1Next Last